Psychemedics Corporation
PMD was delisted on the 12th of December, 2024.
58 hedge funds and large institutions have $79.4M invested in Psychemedics Corporation in 2017 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 22 increasing their positions, 18 reducing their positions, and 4 closing their positions.
125% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 4
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
34% more capital invested
Capital invested by funds: $59.3M → $79.4M (+$20.1M)
22% more repeat investments, than reductions
Existing positions increased: 22 | Existing positions reduced: 18
9% more funds holding
Funds holding: 53 → 58 (+5)
Top Buyers
Top Sellers
PMD Hedge Fund Activity: Q2 2017 in Review
58 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Psychemedics Corporation (PMD) for Q2 2017, worth a combined $79.4M — up 34% from $59.3M a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new PMD positions and 4 closed out — a net gain of 5 holders — while 22 added to existing stakes and 18 trimmed.
The largest buyer was Ativo Capital Management, opening a new position worth an estimated $1.2M. The largest seller was Tieton Capital Management, cutting an estimated $652K.
- 58 institutional investors held Psychemedics Corporation (PMD) as of Q2 2017, up from 53 in Q1 2017.
- Funds reported $79.4M of Psychemedics Corporation stock for Q2 2017, up 34% quarter-over-quarter.
- 9 funds opened new Psychemedics Corporation positions in Q2 2017 and 4 closed out, a net change of +5 holders.
- The largest Psychemedics Corporation buyer in Q2 2017 was Ativo Capital Management, an estimated $1.2M added.
- The largest Psychemedics Corporation seller in Q2 2017 was Tieton Capital Management, an estimated $652K sold.
Based on aggregated 13F filings for Q2 2017.